Literature DB >> 9369290

Association of calcitriol and blood pressure in normotensive men.

E Kristal-Boneh1, P Froom, G Harari, J Ribak.   

Abstract

The purpose of this study was to clarify the possible associations between the serum 1,25-dihydroxyvitamin D (calcitriol) level and blood pressure. Cross-sectional analysis of data was performed. Data collected included levels of serum calcitriol, parathyroid hormone, serum calcium, and blood lead; blood pressure; dietary history; and demographic and anthropometric variables. One hundred normotensive male industrial employees made up the study population. Systolic blood pressure and diastolic blood pressure were main outcome measures. After possible confounders were controlled for, multivariate analyses yielded an inverse, independent, and statistically significant association between calcitriol level and systolic blood pressure (standardized beta= -0.2704, P=.0051). A similar trend of borderline significance was found for the association between calcitriol and diastolic blood pressure (standardized beta= -0.1814, P=.0611). Parathyroid hormone, serum calcium, and blood lead levels were not associated with blood pressure. When subjects were divided into four groups by calcitriol level, those in the lowest quartile showed significantly higher systolic and diastolic blood pressures than those in the upper quartile (difference=11 mmHg, P=.007, and difference=4 mmHg, P=.071, respectively). There is an inverse association between serum calcitriol level and blood pressure. This suggests that in addition to its role in calcium homeostasis, the active metabolite of vitamin D may play a role in determining blood pressure. The differences in both systolic and diastolic blood pressures between the upper and lower quartiles of serum calcitriol were substantial and may be of clinical significance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369290     DOI: 10.1161/01.hyp.30.5.1289

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  41 in total

Review 1.  Regulation of renin expression and blood pressure by vitamin D(3).

Authors:  Curt D Sigmund
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

2.  Vitamin D insufficiency in diabetic retinopathy.

Authors:  John F Payne; Robin Ray; David G Watson; Cecile Delille; Eva Rimler; Julia Cleveland; Michael J Lynn; Vin Tangpricha; Sunil K Srivastava
Journal:  Endocr Pract       Date:  2012 Mar-Apr       Impact factor: 3.443

Review 3.  Should hypertensive patients take vitamin D?

Authors:  Gregoire Wuerzner; Michel Burnier; Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

4.  Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.

Authors:  Corrilynn O Hileman; Vin Tangpricha; Abdus Sattar; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

5.  Association of vitamin D status and blood pressure response after renal denervation.

Authors:  Janine Pöss; Felix Mahfoud; Christian Ukena; Murray David Esler; Markus Schlaich; Dagmara Hering; Bodo Cremers; Ulrich Laufs; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2013-10-31       Impact factor: 5.460

6.  Vitamin D status is not related to development of atrial fibrillation in the community.

Authors:  Michiel Rienstra; Susan Cheng; Martin G Larson; Elizabeth L McCabe; Sarah L Booth; Paul F Jacques; Steven A Lubitz; Xiaoyan Yin; Daniel Levy; Jared W Magnani; Patrick T Ellinor; Emelia J Benjamin; Thomas J Wang
Journal:  Am Heart J       Date:  2011-08-11       Impact factor: 4.749

7.  Association of serum phosphate with vascular and valvular calcification in moderate CKD.

Authors:  Kathryn L Adeney; David S Siscovick; Joachim H Ix; Stephen L Seliger; Michael G Shlipak; Nancy S Jenny; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

8.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Authors:  Yan Chun Li; Juan Kong; Minjie Wei; Zhou-Feng Chen; Shu Q Liu; Li-Ping Cao
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.

Authors:  Jason R Stubbs; Arun Idiculla; Joyce Slusser; Rochelle Menard; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2009-12-10       Impact factor: 10.121

10.  Blood pressure and diabetic nephropathy.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2010-03       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.